PUBLICATIONS

2018-19     2016-17      2014-15     2007-13

2018 - 2019

Willett C.

The Use of Adverse Outcome Pathways (AOPs) to Support Chemical Safety Decisions Within the Context of Integrated Approaches to Testing and Assessment (IATA). In: Kojima H., Seidle T., Spielmann H. (eds) Alternatives to Animal Testing. Springer, Singapore. (2019)

DOI

PDF

Garcia-Reyero, N., Perkins, E.J., Gayen, K., Shoemaker, J.E., Antczak, P., Burgoon, L., Falciani, F., Gutsell, S., Hodges, G., Kienzler, A., Knapen, D., McBride, M., Willett, C., Doyle, F.J.

Chemical Hazard Prediction and Hypothesis Testing Using Quantitative Adverse Outcome Pathways. ALTEX. 2019;36(1):91-102. (2018)

DOI

PDF

Marshall, L.J., Austin, C.P., Casey, W., Fitzpatrick, S.C., Willett, C.

Recommendations toward a human pathway-based approach to disease research. Drug Discov Today. 23(11):1824-1832. (2018)

DOI

PDF

Carusi, A., Davies, M.R., De Grandis, G., Escher, B.I., Hodges, Leung, G.K.M.Y., Whelan, M., Willett, C., and G.T. Ankley.

Harvesting the Promise of AOPs: an assessment and recommendations. Review. Science of the Total Environment, 628–629: 1542–1556. (2018)

DOI

PDF

Willett, K., Fitzpatrick, S., Meek, B., Westmoreland, C.

Use of Adverse Outcome Pathways in Human Risk Assessment and Toxicology. In: A Systems Biology Approach to Advancing Adverse Outcome Pathways for Risk Assessment, Garcia-Reyero, N. and C. Murphy (Eds.). Springer Publishing Company, New York, NY. Pages 349 – 378. ISBN 978-3-319-66084-4 pp 349-378. (2018)

DOI

2016 - 2017

LaLone, C.A., Ankley, G.T., Belanger, S.E., Embry, M.R., Hodges, G., Knapen, D., Munn, S., Perkins, E.J., Rudd, M.A., Villeneuve, D.L., Whelan, M., Willett, C., Zhang, X., Hecker, M.

Advancing the adverse outcome pathway framework-An international horizon scanning approach. Environ Toxicol Chem. 36 (6):1411-1421. (2017)

DOI

PDF

Qu, X.T., Cheng, S-J., Qin, Y., Ke, Y-H.

Adverse Outcome Pathways Guide and toxicity test application. China Surfactant Detergent & Cosmetics. 46(8): 473-478. (2016)

DOI

PDF

Langley, G., I. Adcock, F. Busquet, K. Crofton, E. Csernok, C. Giese, T. Heinonen, K. Herrmann, M. Hofmann-Apitius, B. Landesmann, L. Marshall 11, E. McIvor, A. Muotri, F. Noor, K. Schutte, T. Seidle, A. van de Stolpe, H. Van Esch, C. Willett, and G. Woszczek. 2016.

Towards a 21st century roadmap for biomedical research and drug discovery: Consensus report and recommendations. Drug Discovery Today. 22(2):327-339. (2016)

DOI

PDF

2014 - 2015

Langley, G., Austin, C.P., Balapure, A.K., Birnbaum, L.S., Bucher, J.R., Fentem, J., Fitzpatrick, S.C., Fowle, J.R. 3rd, Kavlock, R.J., Kitano, H., Lidbury, B.A., Muotri, A.R., Peng, S.Q., Sakharov, D., Seidle, T., Trez, T., Tonevitsky, A., van de Stolpe, A., Whelan, M., Willett, C.

Lessons from Toxicology: Developing a 21st-Century Paradigm for Medical Research. Environ Health Perspect. 123(11):A268-72.. (2015)

DOI

PDF

Perkins, E.J., Antczak, P., Burgoon, L., Falciani, F., Garcia-Reyero, N., Gutsell, S., Hodges, G., Kienzler, A., Knapen, D., McBride, M. and Willett, C.

Adverse Outcome Pathways for Regulatory Applications: examination of four case studies with different degrees of completeness and scientific confidence. Tox. Sci. 148 (1): 14-25. (2015)

DOI

 

Willett, C.

Adverse Outcome Pathways: Development and Use in Toxicology. In: Wexler, P. (Ed.), Encyclopedia of Toxicology, 3rd edition vol 1. Elsevier Inc., Academic Press, pp. 95–99. (2014)

 

Willett, C., Caverly Rae, J., Goyak, K.O., Landesmann, B., Minsavage, G., Westmoreland, C.

Pathway-based toxicity: history, current approaches and liver fibrosis and steatosis as prototypes. ALTEX. 2014;31(4):407-21. doi: 10.14573/altex.1401283. (2014)

PDF

Willett, C., Caverly Rae, J., Goyak, K.O., Minsavage, G., Westmoreland, C., Andersen, M., Avigan, M., Duché, D., Harris, G., Hartung, T., Jaeschke, H., Kleensang, A., Landesmann, B., Martos, S., Matevia, M., Toole, C., Rowan, A., Schultz, T., Seed, J., Senior, J., Shah, I., Subramanian, K., Vinken, M., Watkins, P.

Building shared experience to advance practical application of pathway-based toxicology: liver toxicity mode-of-action. ALTEX. 2014;31(4):500-19. doi: 10.14573/altex.1401281. (2014)

PDF

2007 - 2013

Vinken, M., Landesmann, B., Goumenou, M., Vinken, S., Shah, I., Jaeschke, H., Willett, C., Whelan, M., Rogiers, V.

Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury. Toxicol Sci. 2013 Nov;136(1):97-106. (2013)

DOI

PDF